GPCR

Structure Therapeutics Inc. GPCR

NasdaqMid CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-106.16M

Quarter to Jun 30

Free cash flow

$-120.16M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$3.62B total
FMR LLC
$419.18M-7.1%
WELLINGTON MANAGEMENT GROUP LLP
$396.05M+1.6%
Avoro Capital Advisors LLC
$351.84M0.0%
Jupiter Topco LLC
$279.34M--
Deep Track Capital, LP
$254.40M+10.8%
BVF INC/IL
$180.70M-2.7%
MORGAN STANLEY
$150.63M+21.7%
ORBIMED ADVISORS LLC
$118.58M+49.7%
PRINCIPAL FINANCIAL GROUP INC
$94.07M-0.1%
AMERICAN CENTURY COMPANIES INC
$90.28M+17.0%
RTW INVESTMENTS, LP
$86.27MNew
DRIEHAUS CAPITAL MANAGEMENT LLC
$83.36M-1.5%
BAKER BROS. ADVISORS LP
$76.88M0.0%
Casdin Capital, LLC
$63.06M0.0%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$58.29M+41.4%
CAPITOLIS LIQUID GLOBAL MARKETS LLC
$55.88M-9.6%
Siren, L.L.C.
$46.85M-34.3%
PRICE T ROWE ASSOCIATES INC /MD/
$45.38M-57.7%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC
$42.94M+6.7%
Rock Springs Capital Management LP
$34.37M0.0%
abrdn plc
$34.34M+63.3%
FRANKLIN RESOURCES INC
$31.07M+8.9%
BANK OF AMERICA CORP /DE/
$30.24M+148.1%
ALLIANCEBERNSTEIN L.P.
$29.48M-4.2%
BlackRock, Inc.
$27.43M+15.7%
See all 193 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/GPCR

Earnings Per Share

13fpro.ai/company/GPCR

Loading ratio trend…

GPCR insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in GPCR

1 transaction in GPCR reported by 1 member of Congress under the STOCK Act, most recent trade Oct 4, 2023. Reported transactions, not recommendations.

All Congress stock trades →

About Structure Therapeutics Inc. (GPCR): stock profile, AI score and financials

Structure Therapeutics Inc. (GPCR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. GPCR is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), Structure Therapeutics Inc. reports net income of $-106.2M, free cash flow of $-120.2M. Top institutional holders of GPCR by reported 13-F value include FMR, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors, based on the most recent SEC filings. GPCR trades on the Nasdaq exchange and files with the SEC under CIK 1888886. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GPCR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Structure Therapeutics Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1888886 →